This webinar explores contemporary best practice in the treatment of HR+, HER2‑ metastatic and early breast cancer, with a focus on optimising patient outcomes through evidence‑based nursing care.
ABOUT THE WEBINAR:
This webinar explores contemporary best practice in the treatment of HR+, HER2‑ metastatic and early breast cancer, with a focus on optimising patient outcomes through evidence‑based nursing care. We’ll unpack key considerations in CDK4/6 inhibitor therapy, review practical strategies for managing aromatase‑inhibitor–related side effects, and highlight the nurse’s pivotal role in supporting treatment adherence and persistence. Participants will gain practical communication tools to help patients balance treatment necessity with the realities of side‑effect burden, enabling more confident, informed, and sustainable treatment engagement.
MEET THE SPEAKERS:

Oncology Nurse Practitioner, St Vincent’s Private Hospital, East Melbourne
THANKS TO OUR SPONSORS:

Oncology Nurse Practitioner, St Vincent’s Private Hospital, East Melbourne
Marisa has worked in oncology for more than 25 years, including employment interstate and overseas in both the outpatient and inpatient settings in public and private sectors. She has accreditation as both a breast and lung cancer nurse.
In 2019 Marisa completed her Masters of Advanced Nursing Practice at the University of Melbourne and became an Oncology Nurse Practitioner.
She is a member of Cancer Nurses Society Australia (CNSA), Australian college of nurse practitioner, MASCC and previously a committee member for Cancer Nurse Specialist Practice Network (CNPSPN); she is involved with the nurse practitioner course at Monash University.
She is currently undertaking a research project with Monash University focusing on patient education.
She has twice been nominated for HESTA nurse of the year.
Please accept {{cookieConsents}} cookies to view this content